Top Ten Equity Holdings and Exposures

RNS Number : 8121P
Polar Capital Global Health Tst PLC
12 February 2019
 

12th February 2019

 

Polar Capital Global Healthcare Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st January 2019 and full Portfolio listing as at 31st December 2018 available from company's website

 

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 31st January 2019 the top ten equity holdings and the sector and geographic breakdown were as follows:

 

Top 10 Holdings         

%

Johnson & Johnson

8.1%

Novartis

5.4%

Merck & Co

5.3%

Abbott Laboratories

5.1%

UnitedHealth Group

4.8%

Takeda Pharmaceutical

4.7%

Novo Nordisk A/S

4.6%

Anthem

4.4%

CVS Health Corp

4.4%

HCA Holdings

4.2%

Total

51.1%

 

 

 

Sector Exposure

%

Pharmaceuticals

36.0%

Healthcare Equipment

25.7%

Biotechnology

15.8%

Managed Healthcare

9.3%

Life Sciences Tools & Services

9.1%

Drug Retail

4.4%

Healthcare Facilities

4.2%

Healthcare Services

3.0%

Healthcare Supplies

2.4%

Healthcare Technology

0.7%

Education Services

0.4%

Cash

-10.9%

Total

100.0%

 

 

 

Geographic Exposure

%

United States

72.4%

United Kingdom

12.1%

Ireland

5.9%

Japan

5.8%

Switzerland

5.4%

Denmark

4.6%

Spain

3.0%

Sweden

0.7%

Italy

0.6%

Norway

0.4%

Cash

-10.9%

Total

100.0%

 

 

Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 11.10%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference shares.

 

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.co.uk

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUGGUPPPUPBGQP
UK 100

Latest directors dealings